Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase 1 3 Phase 2/3 1 Phase 1/2 1

Status

Terminated 3 Unknown 2 Completed 2 Active not recruiting 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 109 Cyclophosphamide 85 fludarabine 67 Carboplatin 59 Injections 58 Bevacizumab 52 Specimen Handling 42 Gemcitabine 41 Paclitaxel 40 Magnetic Resonance Spectroscopy 40 venetoclax 38 Nivolumab 38 Cisplatin 37 Dexamethasone 35 Biopsy 34 Temozolomide 31 Docetaxel 29 atezolizumab 27 Oxaliplatin 26 Capecitabine 26 Pemetrexed 25 Fluorouracil 25 toripalimab 24 abemaciclib 24 Irinotecan 24 Azacitidine 24 Fulvestrant 23 Rituximab 21 fludarabine phosphate 20 durvalumab 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Recruiting × Alpelisib × Clear all

NCT05563220 2026-01-06

ELEVATE

Stemline Therapeutics, Inc.

Phase 1/2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡